CVInsight® Monitoring System Will Be Demonstrated on Site

 

PITTSBURGH, PA–(Mar 21, 2016) – InteloMed, Inc., an emerging leader and developer of advanced non-invasive systems for patient monitoring and informatics, will be exhibiting the CVInsight® Patient Monitoring & Informatics System for assessing dialysis treatment tolerance at the 33rd Annual National Association of Nephrology Technicians/Technologists Symposium (NANT). The NANT Annual Symposium is described as the world’s largest multi-disciplinary conference on dialysis. This year’s symposium is hosted in Las Vegas, Nevada March 21-24, 2016.

 

“The NANT Annual Symposium is a significant meeting for the dialysis community, focusing on professional development and advances in technology for dialysis treatment, so we are extremely enthusiastic to demonstrate our unique CVInsight® Patient Monitoring and Informatics System to this important group of clinicians,” stated Jill Schiaparelli, InteloMed President and CEO. “Our technology is the first in a new category of advanced non-invasive monitoring options and provides unprecedented insight on the dialysis patient.”

 

Demonstrations of the CVInsight® Monitoring System will be available in the NANT exhibit hall in the InteloMed booth, number 311.

 

About CVInsight® Monitoring System
Providing an unprecedented level of physiologic insight, the CVInsight® Monitoring System is an easy-to-use, multi-parameter system. It empowers clinicians with non-invasive, real-time, dynamic, and actionable information about a patient’s dialysis tolerance. Based on patented and proprietary algorithms, the system clinician set alerts to notify healthcare providers of changes in the patient’s tolerance to dialysis treatment, allowing them to intervene to avoid dialysis interruptions that can have serious patient consequences.

 

The CVInsight® Patient Monitoring and Informatics System is FDA-cleared and CE-marked and has launched commercially.

 

About InteloMed
InteloMed is redefining the standard of care in patient monitoring and informatics through its intelligent, multi-dimensional, non-invasive CVInsight® Patient Monitoring & Informatics System.

The CVInsight® Patient Monitoring System provides real-time insights to inform clinical decisions in a variety of healthcare applications, including in-patient and out-patient facilities, clinics, medical facilities and sleep labs.

 

InteloMed is headquartered in Wexford, PA.

 

For more information, visit us at www.InteloMed.com.

 

About the National Association of Nephrology Technicians/Technologists
The NANT recognizes the roles of the Nephrology Technician and Nephrology Technologist can and will incorporate a variety of responsibilities including, but not limited to: direct care of the dialysis patient, medical equipment maintenance and repair, reuse of hemodialyzers, materials management, quality assurance, and research and development. For more information, visit: www.dialysistech.net.

 

Safe Harbor Statement
Certain statements in this release are “forward-looking” and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain additional capital in order to grow our business, our ability to engage qualified employees, the acceptance of new products by doctors and hospitals, changes in the regulatory environment and healthcare legislation, the need to keep pace with technological changes, our dependence on third party manufacturers to produce components of our technology platform on time and to our specifications, and the successful implementation of our commercial strategies.

 

A CommPro Worldwide PR Event

 

Contacts:

 

PR & Media Contact:

Matt Bird, CEO
CommPro Worldwide

C: +1 (646) 401-4499
E: matt.bird@commpro.com